a month ago
KNSA
AnalystsEva Fortea VerdejoEva Fortea Verdejo's Stock Forecasts
AnalystsEva Fortea Verdejo
Sectors:
Industries:
Analyst Ranking
Top 17%
#848 out of 5072 analysts
Average Return
+36.08%
Win Rate
76%16 out of 21
Risk vs Reward
Poor
Good
Eva Fortea Verdejo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merus NvMRUS | +127.08% | $41.25 | $93.67 | 2025-02-06 - 2025-09-29 | Strong Buy |
Merus NvMRUS | +119.01% | $42.77 | $93.67 | 2025-05-07 - 2025-09-29 | Strong Buy |
Arcus Biosciences IncRCUS | +109.74% | $8.01 | $16.80 | 2025-05-06 - 2025-10-22 | Strong Buy |
Xencor IncXNCR | +81.56% | $7.32 | $13.29 | 2025-08-06 - 2025-10-22 | Strong Buy |
Arcus Biosciences IncRCUS | +81.03% | $9.28 | $16.80 | 2025-08-06 - 2025-10-22 | Strong Buy |
Eva Fortea Verdejo Analyst Color
Get additional color on Eva Fortea Verdejo's coverage of popular stocks
Eva Fortea Verdejo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcus Biosciences IncRCUS | 4 | Strong Buy | $29.00 | +72.62% | Maintains | 4 days ago |
Merus NvMRUS | 5 | Hold | $97.00 | +2.75% | Downgrades | 24 days ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $45.00 | +15.68% | Maintains | a month ago |
Revolution Medicines IncRVMD | 1 | Strong Buy | $70.00 | +32.13% | Maintains | a month ago |
Iteos Therapeutics IncITOS | 7 | Hold | $11.00 | +8.37% | Maintains | 3 months ago |
Xencor IncXNCR | 3 | Strong Buy | $27.00 | +103.16% | Maintains | 3 months ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $44.00 | +53.63% | Initiates Coverage On | 4 months ago |
Bicara Therapeutics IncBCAX | 2 | Hold | $8.00 | -51.37% | Upgrades | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.